Focal Choroidal Excavation (FCE)

Focal Choroidal Excavation (FCE) is a small, deep pit or depression in the choroid layer of the eye that is seen most clearly with detailed imaging, especially optical coherence tomography (OCT). It looks like a localized scoop or hollow in the choroid under the retina, but there is no obvious outward bulge of the eyeball or scleral change as in other conditions. Most of the time, FCE does not cause symptoms and is found by accident when a person has an eye scan for another reason. It can occur alone or together with other eye diseases, and doctors are still learning why it happens. EyeWiki PMC Nature

Focal choroidal excavation is a small, localized “dip” or indentation in the choroid layer of the back of the eye, visible on optical coherence tomography (OCT). It is not caused by a tumor or staphyloma (bulging); instead, it appears as a hollowed-out area where the normal choroidal contour is disrupted while the overlying retina may look relatively preserved. Many people have it by chance and never have symptoms, but in some eyes it associates with vision-affecting complications like central serous chorioretinopathy (CSC) or choroidal neovascularization (CNV). The condition was recognized more frequently with widespread use of high-resolution OCT.EyeWikiPubMed

FCE may be present from birth (congenital) or might develop later in life after other changes or damage in the eye. In many people it stays stable over years, but sometimes it is linked with complications such as abnormal new blood vessel growth under the retina (choroidal neovascularization) or fluid buildup leading to vision changes. EyeWikiNature

Types and Classification

There are several ways doctors describe and classify FCE based on its shape, how the retinal layers lie over it, its location, and underlying choroidal thickness.

Conforming vs Non-conforming:
In the conforming type, the photoreceptor layer of the retina lies directly against the retinal pigment epithelium (RPE) over the excavation, so there is no visible space between them. In the non-conforming type, there is a clear separation and a dark (hyporeflective) space on OCT between the photoreceptors and RPE, sometimes containing debris or fluid. The non-conforming type is more likely to be associated with other mechanical or tractional changes and can reflect subtle instability. EyeWikiNature

Shape-based classification:
Researchers have also divided FCE by the actual shape of the excavation seen on OCT. The most common shapes are cone-shaped, bowl-shaped, or a mixed morphology. Cone-shaped lesions tend to be deeper and more localized, while bowl-shaped ones may be wider and sometimes show irregularities in overlying RPE. EyeWiki

Location:
Excavations can be foveal (in or near the center of the macula where sharp vision occurs) or extrafoveal (off to the side). Subfoveal or juxtafoveal lesions are seen most often. The exact location affects symptom likelihood and potential impact on vision. EyeWiki

Choroidal-thickness based subtypes:
More recent work has further refined FCE types by underlying choroidal thickness measured under the excavation. These include:

• Leptochoroid type (thin choroid, subfoveal choroidal thickness <100 μm),

• Normochoroid type (100–200 μm), and

• Pachychoroid type (thicker choroid, >200 μm).
  These subtypes help link FCE to wider choroidal disorders and may predict associated diseases or risk of change over time. Nature

Causes and Associations

The exact cause of FCE is not fully known; many of the items below are either believed to contribute to its formation or are conditions frequently found together with FCE. In many cases the relationship is associative rather than proven causal.

1. Congenital developmental anomaly: Some FCE cases likely reflect an early abnormality in how the choroid formed, meaning the excavation was present from birth and remains stable. EyeWikiNature

2. Pachychoroid spectrum disease: FCE is considered part of this family of disorders, which involve thickened choroid and dilated vascular layers; the abnormal choroidal circulation may predispose to excavation formation. PMCPMC

3. Central Serous Chorioretinopathy (CSC): This disease of choroidal hyperpermeability and fluid leakage under the retina is frequently seen together with FCE, suggesting shared choroidal dysfunction. PMCPMCScienceDirect

4. Polypoidal Choroidal Vasculopathy (PCV): A variation in vascular choroidal disease with abnormal branching vessels is often in the pachychoroid family and is linked to FCE. NatureNature

5. Pachychoroid neovasculopathy: Abnormal new vessel growth in the setting of pachychoroid changes can coexist with or underlie FCE. Nature

6. Neovascular Age-related Macular Degeneration (nAMD): FCE has been seen alongside choroidal neovascularization in AMD, possibly due to shared outer retinal and choroidal stress. IOVSNature

7. Bestrophinopathy (Best disease): A retinal dystrophy affecting RPE function; FCE has been reported in some patients with Best disease, suggesting a link via abnormal RPE-choroid interaction. EyeWiki

8. Multiple Evanescent White Dot Syndrome (MEWDS): An inflammatory retinal condition that may trigger acquired FCE through localized inflammation and healing. PMC

9. Multifocal Choroiditis / Punctate Inner Choroidopathy: Inflammatory lesions in the outer retina and choroid can lead to scarring and localized excavation. EyeWiki

10. Sarcoid choroiditis / posterior uveitis: Granulomatous inflammation in the choroid from sarcoidosis or similar diseases can lead to secondary structural changes including excavation. EyeWiki

11. Tubercular choroiditis: Chronic infectious inflammation with scarring in the choroid may be linked to acquired forms of FCE. EyeWiki

12. Epstein-Barr Virus (EBV) infection: EBV has been observed in correlation with FCE, possibly through local inflammation or immune-mediated tissue alteration. PMC

13. Other posterior segment inflammatory diseases: Idiopathic or autoimmune inflammation causing choroidal scarring may create or unmask excavations. EyeWiki

14. Retinal dystrophies: Certain genetic retinal diseases have been associated with FCE, likely due to long-standing outer retinal/choroidal stress or structural vulnerability. EyeWiki

15. High myopia: Some initial reports described FCE in myopic eyes; axial elongation and related choroidal thinning or tension could contribute. Nature

16. Choroidal neovascularization (secondary): Abnormal new vessels may both arise in the setting of an existing FCE or contribute to its modification, especially if they cause fluid or scarring. Nature

17. Tractional macular pathologies (e.g., epiretinal membrane, macular pucker): Mechanical distortion above the excavation may influence its nonconforming appearance or stability. Nature

18. Choroidal vascular congestion / hyperpermeability: Independent of a defined pachychoroid subtype, localized venous overload or congestion can disturb tissue and promote excavation formation. Nature

19. Choriocapillaris ischemia: Reduced blood flow in the choriocapillaris may lead to localized tissue loss or remodeling manifesting as excavation, particularly when combined with inflammation. Nature

20. Idiopathic: In many patients, no clear associated disease is identified, and the excavation appears without an obvious trigger; such cases are labeled idiopathic. EyeWikiNature

Note: Many of these are associations, and in individual cases the direction of cause and effect can be unclear. Some excavations may predate or predispose to other local changes, while others may result from earlier disease. NatureEyeWiki

Symptoms

FCE is often silent, but when people have symptoms, they are usually related to how the excavation affects the overlying retina or causes secondary changes. Below are 15 symptoms that patients with FCE might notice, either directly or from related complications:

1. No symptoms (asymptomatic): The most common presentation; many patients have FCE detected during an eye exam with no complaints. EyeWiki

2. Mild blurred vision: Slight reduction in clarity, especially if the excavation is under the central macula. EyeWikiNature

3. Decreased visual acuity: Noticeable loss in sharpness of vision, especially if FCE is associated with other changes like neovascularization. EyeWikiNature

4. Metamorphopsia: Straight lines appear wavy or distorted, usually when the macula is involved. EyeWiki

5. Central scotoma: A dark or blind spot in the center of vision from direct involvement of the fovea or associated fluid. EyeWiki

6. Micropsia: Objects may look smaller than they are, often due to subtle retinal displacement. EyeWiki

7. Dyschromatopsia / color changes: Mild changes in color perception when the outer retina or RPE is altered. EyeWiki

8. Reduced contrast sensitivity: Difficulty seeing in low contrast situations, which can happen if the macular architecture is disturbed. EyeWiki

9. Visual distortion with near tasks: Trouble reading or focusing on close work due to subtle central irregularities. EyeWiki

10. Reading fatigue / eye strain: Increased effort to maintain clarity when vision is subtly impaired. EyeWiki

11. Sudden vision loss: Typically from a complication such as choroidal neovascularization or serous detachment overlying the excavation. Nature

12. Floaters or shimmering (less common): May arise if associated vitreoretinal traction or secondary changes occur. Nature

13. Photopsia (light flashes): Can occur with tractional stress or if secondary retinal irritation exists. Nature

14. Difficulty with color contrast: Subtle changes making it harder to distinguish shades, especially in low lighting. EyeWiki

15. Peripheral visual field changes (rare): If excavation coexists with larger macular or chorioretinal disease, broader field effects may be noted. PMC

Because many of these symptoms overlap with other macular and choroidal diseases, careful imaging and clinical correlation are needed to attribute them properly to FCE. EyeWikiPMC

Diagnostic Tests

Diagnosing FCE relies on combining a clinical eye exam with functional testing and imaging. Here the 20 key diagnostic tools are grouped and explained.

A. Physical Examination and Manual / Functional Tests

1. Visual acuity measurement: Using a standardized chart to quantify how clearly the patient sees. This is the basic test to detect any vision loss. PMC

2. Pupillary reflex evaluation: Checking how pupils react to light can reveal associated optic nerve or retinal dysfunction that might accompany complex cases. PMC

3. Intraocular pressure (IOP) measurement: While not directly diagnostic for FCE, assessing pressure helps rule out coexisting glaucoma or other contributing optic changes. PMC

4. Slit-lamp examination with dilated fundus exam / indirect ophthalmoscopy: Allows the doctor to directly view the back of the eye, look for any abnormal-looking yellowish or subtle lesions near the macula, and assess overall retinal health. EyeWikiPMC

5. Amsler grid test: A simple manual grid test that the patient uses to report distortions (metamorphopsia) or central scotomas, useful when FCE involves the macula. EyeWiki

6. Color vision testing: Detects subtle changes in color perception that may accompany macular or RPE abnormalities over excavations. PMC

7. Contrast sensitivity testing: Measures how well a person can distinguish between slight differences in shades; useful if FCE affects image quality centrally. PMC

8. Microperimetry: Maps the visual sensitivity across the macula while correlating directly with anatomical features; it can show reduced sensitivity over or near an excavation. PMC

9. Automated visual field testing (perimetry): Assesses broader visual field defects which might emerge from associated complications or to differentiate central from peripheral visual issues. PMC

B. Electrodiagnostic Tests

10. Multifocal electroretinography (mfERG): Measures localized retinal electrical responses, useful to see if overlying retina near the excavation is functioning normally or impaired. PMC

11. Full-field electroretinography (ffERG): Gives a global measure of retinal function and helps rule out widespread retinal dystrophies when FCE is seen in the setting of possible inherited disease. PMC

12. Electrooculography (EOG): Evaluates the health and function of the retinal pigment epithelium, which may be altered in some conditions associated with FCE (e.g., Best disease). PMC

C. Imaging Tests

13. Spectral-domain OCT (SD-OCT) with Enhanced Depth Imaging (EDI): The most important test to identify and characterize FCE. It shows the excavation’s shape, depth, whether it is conforming or non-conforming, and the relationship of photoreceptors to the RPE. EDI allows better visualization of deeper choroidal layers. PMCPMC

14. Swept-source OCT (SS-OCT): Uses longer wavelength light to see deeper into the choroid and can better assess choroidal thickness, pachyvessels, and subtle associations, improving detection and classification. Nature

15. OCT angiography (OCTA): Non-invasive blood flow imaging that can detect associated abnormal vessel growth (choroidal neovascularization) near or within an FCE without dye injection. PMCNature

16. Fluorescein angiography (FA): Injected dye outlines retinal circulation; used to detect leakage or abnormal vessels that may accompany FCE, especially if secondary neovascularization or serous detachments are suspected. PMC

17. Indocyanine green angiography (ICGA): Better visualizes deeper choroidal circulation; helpful in evaluating pachychoroid features, PCV, or choroidal vascular congestion linked to FCE. PMC

18. Fundus autofluorescence (FAF): Shows RPE health; changes in autofluorescence patterns over an excavation or in its margins can suggest stress or early dysfunction. EyeWikiPMC

19. Color fundus photography: Documents the appearance of the posterior pole, helps localize the excavation, and provides a reference for changes over time. Nature

20. B-scan ultrasonography: Ultrasound of the eye can help exclude other deeper masses or staphylomas and is useful when media clarity is poor; though FCE itself is usually subtle on ultrasound, it helps rule out mimics. PMC

Non-Pharmacological Treatments (Therapies and Others)

(Note: FCE often does not require active treatment; many “treatments” are monitoring, prevention of complications, and vision support.)

1. Observation with Serial OCT
   Regular imaging to watch the excavation for stability or development of complications like fluid accumulation or CNV. Purpose: early detection. Mechanism: high-resolution OCT reveals subtle changes before symptoms.ScienceDirect

2. Patient Education and Awareness
   Teaching patients what symptoms to watch for (e.g., distortion, blurring) so they seek care early. Purpose: prompt intervention. Mechanism: informed self-monitoring reduces delay. (General standard of care inferred from clinical practice guidelines.)

3. Low Vision Rehabilitation
   For eyes with decreased vision from associated pathology, specialized training, magnifiers, lighting, and adaptive strategies help maximize remaining sight. Purpose: improve independence and quality of life. Mechanism: optimize use of residual vision through devices and exercises.PMCAmerican Osteopathic Association

4. Visual Aids / Assistive Devices (non-surgical)
   Handheld magnifiers, electronic readers, contrast-enhancing glasses reduce functional impact when central vision is affected. Purpose: functional vision support. Mechanism: enlargement or enhancement of images to compensate for scotomas.Johns Hopkins Medicine

5. Stress Reduction Techniques
   Because stress is a known trigger for CSC (which can coexist with or complicate FCE), managing stress via mindfulness, therapy, or relaxation reduces risk of fluid leakage. Purpose: reduce secondary fluid-related complications. Mechanism: lower endogenous cortisol and sympathetic drive implicated in CSC.BioMed Central

6. Sleep Hygiene / Treat Sleep Apnea
   Poor sleep and obstructive sleep apnea may worsen choroidal circulation and pachychoroid-related conditions. Purpose: stabilize choroidal physiology. Mechanism: improved oxygenation and decreased nocturnal hemodynamic swings indirectly protect retinal structures.BioMed Central

7. Avoidance or Minimization of Systemic Corticosteroids
   Corticosteroids are risk factors for CSC; avoiding them when possible lowers chance of associated subretinal fluid. Purpose: prevent secondary serous detachments. Mechanism: steroid-induced choroidal hyperpermeability.Nature

8. Control of Systemic Hypertension
   Good blood pressure control reduces choroidal vascular stress and may lessen progression of coexisting vascular compromise. Purpose: protect choroidal circulation. Mechanism: avoids fluctuations that can exacerbate leakage or ischemia. (General vascular health principle consistent with ocular disease prevention.)

9. Smoking Cessation
   Smoking impairs microvascular circulation and promotes oxidative stress in the choroid and retina. Purpose: reduce long-term retinal damage risk. Mechanism: improved perfusion and reduced free radical injury. (Supported by broad ophthalmic epidemiology—e.g., AMD risk factors, extrapolated for general ocular health.)

10. UV and Blue Light Protection (Sunglasses / Screen Breaks)
    Filtering harmful light reduces cumulative oxidative stress to the retina. Purpose: long-term retinal preservation. Mechanism: limiting phototoxicity and reactive oxygen species formation.Johns Hopkins Medicine

11. Lifestyle Diet Optimization (see detailed diet section later)
    Eating foods rich in antioxidants and anti-inflammatory nutrients supports retinal health. Purpose: biochemical protection. Mechanism: supply retinal cells with micronutrients that scavenge free radicals.PMCEyeWiki

12. Digital Eye Strain Mitigation
    Regular breaks, proper lighting, and ergonomic screen use reduce eye fatigue that could compound visual discomfort. Purpose: improve subjective clarity and comfort. Mechanism: preventing accommodative strain and dry eye. (General ophthalmic guidance.)

13. Regular Comprehensive Eye Exams
    Early detection of changes or development of complications like CNV allows timely treatment. Purpose: surveillance. Mechanism: professional evaluation using imaging and exam techniques.ScienceDirect

14. Microperimetry Monitoring
    Functional mapping of macular sensitivity can detect subtle functional decline before acuity loss. Purpose: early functional detection. Mechanism: correlates structural defects with visual field sensitivity. (Standard in macular disease management.)

15. Avoidance of Valsalva and Excessive Straining
    Severe transient rises in intraocular pressure or venous pressure might exacerbate choroidal congestion. Purpose: minimize transient choroidal stress. Mechanism: limits sudden hemodynamic shifts. (Physiologic rationale.)

16. Psychological Support / Counseling
    Vision changes can cause anxiety/depression; support maintains mental health and adherence to follow-up. Purpose: holistic care. Mechanism: coping strategies reduce stress-related exacerbation.PMC

17. Control of Metabolic Risk Factors (e.g., obesity, diabetes)
    Systemic metabolic health supports microvascular integrity in the eye. Purpose: reduce chronic vascular insults. Mechanism: less endothelial dysfunction. (Generalizable from vascular ocular disease literature.)

18. Avoidance of Unnecessary Ocular Surgery or Trauma
    Minimizing risk of inflammation that could secondarily affect choroidal dynamics. Purpose: prevent iatrogenic exacerbation. Mechanism: reduce inflammatory mediators and leakage.

19. Monitoring for Associated Pachychoroid Spectrum Diseases
    Since FCE can co-occur with CSC or pachychoroid neovasculopathy, proactive surveillance for these conditions helps timely intervention. Purpose: comprehensive care. Mechanism: tailored imaging and clinical correlation.ScienceDirectWiley Online Library

20. Vision Simulation and Planning (for severe cases)
    For lasting central vision defects, planning life adjustments (work, driving) and simulating future needs reduces risk and improves independence. Purpose: adaptive long-term management. Mechanism: anticipatory functional planning.

 Drug Treatments

Important: FCE itself usually does not have a direct pharmacologic cure. Drugs are used when complications like choroidal neovascularization (CNV) or central serous chorioretinopathy (CSC) occur.

1. Bevacizumab (anti-VEGF)

   • Class: Monoclonal antibody against vascular endothelial growth factor (VEGF).

   • Dosage/Timing: Intravitreal injection, typically 1.25 mg every 4–6 weeks initially, adjusted by response.

   • Purpose: Treat CNV that may develop in association with FCE, reducing leakage and preserving vision.

   • Mechanism: Blocks VEGF to reduce abnormal blood vessel growth and permeability.

   • Side Effects: Endophthalmitis, increased intraocular pressure, intraocular inflammation, systemic thromboembolic risk (low).IOVS

2. Ranibizumab (anti-VEGF)

   • Class: Fragment of anti-VEGF antibody optimized for ocular use.

   • Dosage: Intravitreal 0.5 mg monthly, then as guided by disease activity.

   • Purpose/Mechanism: Similar to bevacizumab; used for CNV with better-defined ocular pharmacokinetics.

   • Side Effects: Similar intravitreal injection risks.JAMA Network

3. Aflibercept (anti-VEGF fusion protein)

   • Class: VEGF trap binding VEGF-A, VEGF-B, and placental growth factor.

   • Dosage: Intravitreal 2 mg every 8 weeks after loading.

   • Purpose: CNV management and leakage control.

   • Mechanism: High-affinity VEGF binding to prevent neovascular growth.

   • Side Effects: Injection-related risks; possible systemic effects are rare.IOVS

4. Verteporfin (used in Photodynamic Therapy, PDT)

   • Class: Photosensitizer.

   • Dosage: Intravenous infusion followed by non-thermal laser activation (half-dose or half-fluence protocols often used for CSC).

   • Purpose: Treat CSC or CNV with localized vascular closure.

   • Mechanism: Activated verteporfin generates reactive oxygen species in abnormal choroidal vessels, causing selective occlusion.

   • Side Effects: Transient vision changes, photosensitivity; rare choroidal ischemia.ScienceDirectNatureIOVS

5. Eplerenone

   • Class: Mineralocorticoid receptor antagonist.

   • Dosage: Often 25–50 mg orally daily, adjusted per tolerance.

   • Purpose: Off-label treatment for chronic CSC, which may coexist or worsen in eyes with FCE.

   • Mechanism: Modulates choroidal vascular permeability by blocking mineralocorticoid effects on choroidal vasculature.

   • Side Effects: Hyperkalemia, renal function changes, mild gynecomastia (less than spironolactone).BioMed CentralWiley Online Library

6. Spironolactone

   • Class: Mineralocorticoid receptor antagonist.

   • Dosage: Typically 25–50 mg orally daily.

   • Purpose/Mechanism: Similar to eplerenone; used in some chronic CSC cases.

   • Side Effects: Hormonal effects (breast tenderness, menstrual irregularities), hyperkalemia.BioMed CentralWiley Online Library

7. Acetazolamide

   • Class: Carbonic anhydrase inhibitor.

   • Dosage: Oral 250 mg to 500 mg twice daily, short courses.

   • Purpose: Rarely used to support RPE pump function and reduce subretinal fluid in persistent serous detachments.

   • Mechanism: Lowers intraocular fluid dynamics and may enhance fluid transport across RPE.

   • Side Effects: Paresthesia, kidney stones, metabolic acidosis, electrolyte imbalance. (Evidence is limited and empirical in chronic subretinal fluid scenarios.)

8. Rifampin

   • Class: Antibiotic with off-label effect reported in chronic CSC.

   • Dosage: Typically 300 mg twice daily for limited duration in small studies.

   • Purpose: Some reports suggest benefit for chronic CSC unresponsive to other therapy.

   • Mechanism: May induce hepatic metabolism altering corticosteroid levels or modulate choroidal inflammation.

   • Side Effects: Hepatotoxicity, drug interactions, orange discoloration of bodily fluids. (Evidence weak, experimental.)BioMed Central

9. Topical Nonsteroidal Anti-inflammatory Drugs (NSAIDs) (limited/adjunctive)

   • Class: COX inhibitors.

   • Usage: Sometimes tried for mild inflammatory components or to relieve discomfort; not proven to reverse FCE.

   • Purpose/Mechanism: Reduce surface inflammation; no strong evidence for structural change.

10. Avoidance of Systemic Corticosteroids (reverse of treatment but critical in management)

    • Rationale: Since steroids can worsen or precipitate CSC, stopping systemic steroids can lead to resolution of associated serous detachments.

    • Mechanism: Removal of choroidal hyperpermeability trigger.Nature

Note: Many of these drugs are used off-label for the complications around FCE; decisions must be individualized by an ophthalmologist.ScienceDirectWiley Online Library

Dietary Molecular Supplements

(Primarily supportive for retinal health; not cures for FCE but may help overall choroidal/retinal resilience.)

1. Lutein

   • Dosage: 6–10 mg daily.

   • Function: Filters blue light, reduces oxidative stress in the macula.

   • Mechanism: Accumulates in macular pigment, scavenges free radicals. Evidence supports enhancement of macular pigment and visual function.PMCScienceDirect

2. Zeaxanthin

   • Dosage: 2 mg daily (often combined with lutein).

   • Function/Mechanism: Works with lutein to absorb high-energy blue light and protect against photo-oxidative damage.PMCScienceDirect

3. Omega-3 Fatty Acids (DHA/EPA)

   • Dosage: ~1000 mg combined EPA/DHA daily.

   • Function: Anti-inflammatory support and membrane stabilization in retinal cells.

   • Mechanism: Modulates inflammatory mediators, supports photoreceptor health, possibly reduces risk of retinal degeneration.PMCIOVS

4. Vitamin C

   • Dosage: 500 mg twice daily (with medical guidance).

   • Function: Antioxidant protecting ocular tissues.

   • Mechanism: Neutralizes free radicals, supports collagen and capillary health. Benefit shown in combination formulas reducing progression in macular degeneration risk groups.National Eye InstituteMDPI

5. Vitamin E

   • Dosage: 400 IU daily (as part of balanced formula).

   • Function/Mechanism: Lipid-soluble antioxidant protecting photoreceptor membranes from oxidative stress.PMCMDPI

6. Zinc

   • Dosage: 25–80 mg (often 80 mg in AREDS but with copper to prevent deficiency).

   • Function: Cofactor for antioxidant enzymes and supports retinal pigment epithelium.

   • Mechanism: Stabilizes cell membranes and reduces oxidative damage.National Eye InstituteAmerican Macular Degeneration Foundation

7. Astaxanthin

   • Dosage: Commonly 4–12 mg daily in supplement form.

   • Function: Potent antioxidant with mitochondrial protection.

   • Mechanism: Crosses cell membranes to reduce oxidative stress in ocular tissues; emerging evidence for retinal protection. (General antioxidant rationale; specific retinal studies growing.)MDPI

8. Resveratrol

   • Dosage: 100–500 mg daily in studied supplements.

   • Function: Anti-inflammatory and antioxidant signaling modulator.

   • Mechanism: Activates protective pathways (e.g., SIRT1) that can reduce cellular aging and stress in ocular cells.Johns Hopkins Medicine

9. N-Acetylcysteine (NAC)

   • Dosage: 600–1200 mg daily.

   • Function: Precursor to glutathione, a major cellular antioxidant.

   • Mechanism: Boosts intracellular glutathione to neutralize reactive oxygen species in retinal pigment epithelium and photoreceptors.Johns Hopkins Medicine

10. Bilberry / Anthocyanins

    • Dosage: Variable; typical extracts standardized to 25% anthocyanins, 80–160 mg twice daily.

    • Function: Microvascular support and antioxidant.

    • Mechanism: May improve capillary strength and scavenge free radicals; evidence is mixed but used traditionally for vision. (Limited strong RCT evidence; more supportive than definitive.)

Note: If using high-dose combinations (like AREDS-type), smokers should avoid beta-carotene–containing formulas due to lung cancer risk; newer AREDS2 formulations replace beta-carotene with lutein/zeaxanthin.RNIBAmerican Macular Degeneration Foundation

Regenerative/Stem Cell or Experimental Therapies

(These are primarily under investigation for other retinal/choroidal degenerative diseases and are not standard or proven treatments for FCE. They illustrate the frontier of regenerative ophthalmology.)

1. Human Embryonic Stem Cell–Derived Retinal Pigment Epithelium (hESC-RPE) Transplantation

   • Dosage/Form: Subretinal injection of RPE cell suspension or patch.

   • Function: Replace damaged RPE in diseases like wet or dry AMD.

   • Mechanism: Restores support to photoreceptors. Early trials show safety and some functional stabilization.Nature

2. Induced Pluripotent Stem Cell–Derived RPE Transplantation (iPSC-RPE)

   • Function: Similar to hESC-RPE but derived from patient-specific iPSCs to reduce rejection.

   • Mechanism: Replaces dysfunctional RPE. Ongoing early-phase studies are evaluating safety/efficacy.ophthalmologyscience.org

3. RPE Cell Sheet Transplantation / Tissue-Engineered RPE

   • Function: Implantation of organized RPE monolayer (sheet) to better mimic native architecture.

   • Mechanism: Provides structural and functional support to overlying photoreceptors. Advances improving survival and integration are reported.PMCOxford Academic

4. Mesenchymal Stem Cell–Based Therapy for Retinal Support

   • Function: Paracrine support and potential modulation of inflammation in retinal degenerative conditions.

   • Mechanism: Secretion of trophic factors, immune modulation. Early work shows promise in degenerative retinal diseases.WJGnetBioMed Central

5. Retinal Prosthetic / Implant Devices (e.g., Advanced Dry AMD Implants)

   • Function: For advanced degeneration, electronic implants can restore limited visual perception.

   • Mechanism: Bypass damaged photoreceptors to stimulate remaining retinal neurons; long-term follow-up shows tolerability.ScienceDirect

6. Cell Therapy Meta-Analytic Evidence for Retinal Degeneration

   • Context: General supportive data on the evolving efficacy and safety of cell-based therapies for retinal diseases, suggesting future relevance for structural chorioretinal disorders.BioMed Central

Important: None of these are approved or indicated for isolated FCE currently. Their mention is to inform the reader of the research landscape.

Surgical or Procedural Interventions

FCE rarely needs surgery directly. Procedures are usually for complications or vision support:

1. Pars Plana Vitrectomy with Internal Limiting Membrane (ILM) Peel

   • Why Done: If associated macular traction or epiretinal membrane forms causing distortion.

   • Purpose: Relieve mechanical distortion to improve vision. Mechanism: removes tangential traction.

2. Surgical Removal of Choroidal Neovascular Membrane (CNV) (rare)

   • Why Done: Historically considered when anti-VEGF fails; now uncommon.

   • Purpose: Physically remove abnormal vessels. Mechanism: excision to prevent leakage.

3. Macular Translocation Surgery

   • Why Done: Severe coexisting maculopathy where the fovea is relocated to healthier retina (very rare).

   • Purpose: Attempt to restore central vision in complex cases. Mechanism: reposition retina relative to pathology.

4. Implantation of Telescopic/Low Vision Intraocular Devices

   • Why Done: To magnify images for patients with central vision loss from secondary damage.

   • Purpose: Improve functional vision. Mechanism: optical magnification inside the eye to expand usable visual field.

5. Cataract Surgery (if coexistent)

   • Why Done: Improve clarity of vision if cataract coexists and is limiting visual function.

   • Purpose: Remove lens opacity to maximize residual macular function. Mechanism: replace cloudy lens with clear implant.

Preventions

Because FCE is structural and often congenital, prevention of FCE itself is not possible, but these steps help prevent complications:

1. Regular eye exams with OCT monitoring.ScienceDirect

2. Avoid unnecessary corticosteroids.Nature

3. Manage stress with behavioral techniques.BioMed Central

4. Control blood pressure and metabolic health.

5. Stop smoking.

6. Maintain healthy sleep / treat sleep apnea.BioMed Central

7. Protect eyes from UV and excessive blue light.Johns Hopkins Medicine

8. Eat a nutrient-rich diet to support retinal health.PMCEyeWiki

9. Avoid stimulants or lifestyle triggers known to aggravate CSC (e.g., extreme caffeine or sympathomimetics).BioMed Central

10. Early treatment of associated pachychoroid conditions like CSC to prevent chronic damage.Wiley Online Library

When to See a Doctor

• Sudden blurring or loss of central vision.

• Distortion of lines (metamorphopsia).

• New floaters or flashes suggesting secondary complications.

• Persistent gray or dark spot in vision (scotoma).

• Signs of choroidal neovascularization (e.g., sudden distortion).ScienceDirect

• Vision not recovering after what seemed like mild disturbance.

• Noticed change during self-monitoring (Amsler grid).

• Chronic subretinal fluid lasting more than several weeks.

• Any new symptoms in the previously stable eye with known FCE.

• Before starting systemic corticosteroids or medications that could affect choroidal circulation.Nature

What to Eat and What to Avoid

What to Eat 

1. Leafy greens (spinach, kale) for lutein/zeaxanthin.PMC

2. Fatty fish (salmon, mackerel) for omega-3s.IOVS

3. Citrus fruits for vitamin C.PMC

4. Nuts and seeds for vitamin E and zinc.American Macular Degeneration Foundation

5. Eggs (macular carotenoids).All About Vision

6. Berries (antioxidants).Johns Hopkins Medicine

7. Whole grains for stable blood sugar, indirect vascular health.

8. Lean proteins (support tissue repair).

9. Colorful vegetables (beta-carotene, vitamin A precursors).Johns Hopkins Medicine

10. Adequate hydration to support ocular surface and circulation.

What to Avoid 

1. Smoking.

2. Excessive alcohol.

3. High-sugar/high-glycemic meals that can impair microvascular health.EyeWiki

4. Processed trans fats (systemic inflammation).

5. Unnecessary systemic corticosteroids.Nature

6. Excessive caffeine or sympathomimetics (may trigger CSC).BioMed Central

7. Very high sodium if fluid balance issues arise.

8. Nutrient-poor “empty” calories that displace protective foods.

9. Overconsumption of beta-carotene supplements in smokers (lung cancer risk).RNIB

10. Prolonged screen time without breaks (indirect strain).

Fifteen Frequently Asked Questions (FAQs)

1. What causes focal choroidal excavation?
   The exact cause is unclear. It may be developmental or due to localized structural changes in the choroid. Some think it arises from focal scarring or congenital remodeling.PubMed

2. Is FCE dangerous?
   Most of the time it is harmless and stable. Problems arise if it leads to complications like central serous chorioretinopathy or choroidal neovascularization.ScienceDirect

3. Can FCE cause blindness?
   Rarely. If it is associated with CNV or chronic fluid causing macular damage and left untreated, vision can be permanently reduced. Early detection and treatment of complications prevent most severe outcomes.IOVSWiley Online Library

4. What is the difference between conforming and non-conforming FCE?
   Conforming means retina stays against the excavation; non-conforming has a tiny space suggesting mild fluid separation.ScienceDirect

5. How is FCE diagnosed?
   Primarily by OCT imaging, which shows the excavation and helps monitor for fluid or CNV. Additional imaging (fluorescein angiography, indocyanine green) may assess associated vascular issues.ScienceDirect

6. Does FCE get worse over time?
   Many remain stable for years. Worsening usually comes from new associated disease (like CSC or CNV), not the excavation itself.PubMed

7. Can treatment remove the excavation?
   No known therapy reliably “fills in” the excavation; treatment focuses on complications. Observation is the main approach if asymptomatic.ScienceDirect

8. What treatments are used if vision is affected?
   Anti-VEGF injections for CNV, photodynamic therapy for certain choroidal leakage, and mineralocorticoid antagonists for chronic CSC are used depending on the associated problem.JAMA NetworkWiley Online Library

9. Can lifestyle change help?
   Yes. Reducing stress, avoiding steroids, managing blood pressure, eating nutrient-rich foods, and quitting smoking support eye health and may reduce risk of fluid-related complications.BioMed CentralPMC

10. Should I take supplements?
    Supplements like lutein, zeaxanthin, omega-3s, vitamins C/E, and zinc support general retinal health. If you have coexisting macular risk (e.g., early AMD), AREDS2-type formulas may help. Smokers should avoid beta-carotene formulations.RNIBAmerican Macular Degeneration Foundation

11. Do I need surgery for FCE?
    Not for the excavation itself. Surgery is only for rare secondary problems (e.g., traction membranes or complicated CNV) or to improve vision via low vision implants.

12. Is FCE hereditary?
    There is no strong evidence of simple inheritance; most cases appear sporadic. Research is ongoing.PubMed

13. Can FCE appear in both eyes?
    Yes, it can be unilateral or bilateral, though one eye is more commonly affected. Imaging both eyes is standard.ScienceDirect

14. How often should I get checked?
    If stable and asymptomatic, annual or biannual exams with OCT may suffice. Any new symptoms warrant immediate evaluation.ScienceDirect

15. Are there future treatments coming?
    Research in retinal regenerative medicine (e.g., RPE stem cell transplants, cell-sheet therapies) is advancing, but these are not currently indicated for isolated FCE. They reflect how retinal health interventions may evolve.PMCWJGnet

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: August 04, 2025.

Previous

Floppy Eyelid Syndrome (FES)

Next

Focal Scleral Nodule (FSN)

Related Articles

Added to wishlistRemoved from wishlist 0

Congenital Cataract Caused by Mutation in EPHA2

Added to wishlistRemoved from wishlist 0

Cataract 6 Multiple Types

Added to wishlistRemoved from wishlist 0

Cataract 40 with or without Microcornea

Added to wishlistRemoved from wishlist 0

Cataract 4 Multiple Types with or without Microcornea